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Abstract
Background: In 2006, we found healthy subjects carrying ST131 Escherichia coli in their intestinal microbiota
consisting of two populations: a subdominant population of fluoroquinolone-resistant E. coli belonging to subclone
H30 (H30-R or subclade C1), the current worldwide dominant ST131 subclone, and a dominant E. coli population
composed of antibiotic-susceptible E. coli belonging to subclone H22 (clade B), the precursor of subclone H30. We
sequenced the whole genome of fecal H22 strain S250, compared it to the genomes of ExPEC ST131 H30-Rx strain
JJ1886 and commensal ST131 H41 strain SE15, sought the H22-H30 genomic differences in our fecal strains and
assessed their phenotypic consequences.
Results: We detected 173 genes found in the Virulence Factor Database, of which 148 were shared by the three
ST131 genomes, whereas some were genome-specific, notably those allowing determination of virotype (D for
S250 and C for JJ1886). We found three sequences of the FimH site involved in adhesion: two in S250 and SE15
close and identical, respectively, to that previously reported to confer strong intestinal adhesion, and one in JJ1886,
corresponding to that commonly present in uropathogenic E. coli. Among the genes involved in sugar metabolism,
one encoding a gluconate kinase lacked in S250 and JJ1886. Although this gene was also absent in both our fecal
H22 and H30-R strains, H22 strains showed a higher capacity to grow in minimal medium with gluconate. Among
the genes involved in gluconate metabolism, only the ghrB gene differed between S250/H22 and JJ1886/H30-R
strains, resulting in different gluconate reductases. Of the genes involved in biofilm formation, two were absent in
the three genomes and one, fimB, in the JJ1886 genome. Our fecal H30-R strains lacking intact fimB displayed
delayed biofilm formation relative to our fecal H22 strains. The H22 strains differed by subclade B type and plasmid
content, whereas the H30-R strains were identical.
Conclusions: Phenotypic analysis of our fecal strains based on observed genomic differences between S250 and
JJ1886 strains suggests the presence of traits related to bacterial commensalism in our H22 strains and traits
commonly found in uropathogenic E. coli in our H30-R strains.
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Background
Phylogenetic group B2, sequence type (ST) 131 Escheri-
chia coli has been a worldwide dominant human extra-
intestinal pathogenic E. coli (ExPEC) since the beginning
of the 2000s, and is among those resistant to fluoroqui-
nolones and/or producing the extended-spectrum β-
lactamase (ESBL) CTX-M-15 [1]. Its dominance was
shown to be driven by the expansion of a subclone har-
boring type 1 fimbriae-encoding fimH allele 30 (sub-
clone H30), comprised of mostly strains resistant to
fluoroquinolones (H30-R) [2]. Within this subclone, a
subgroup called H30-Rx, mostly comprising strains re-
sistant to fluoroquinolones and producing CTX-M-15,
has quickly emerged and disseminated [2]. The evolu-
tionary history of clone ST131 revealed that before the
emergence and dissemination of subclone H30 (also
called clade C), the ST131 population consisted of
mostly two subclones called H22 (clade B) and H41
(clade A), with subclone H22 comprised of mostly
fluoroquinolone-susceptible isolates [3–5]. It also re-
vealed that subclone H22 was the precursor of subclone
H30 and that separate F-type plasmids have shaped the
evolution of subclone H30 [2, 3, 5, 6]. The most recent
ST131 E. coli phylogenetic reconstruction carried out by
Ben Zakour et al. using 3779 non-recombinant single
nucleotide polymorphisms (SNP) found in the high qual-
ity genomes of 172 clade B and C strains, identified five
B subclades, for which the independent evolutionary tra-
jectories are characterized by successive insertions and a
recombination from ancestral H22 (subclade B1) [7].
Subclade B2 is characterized by a Flag-2 locus insertion,
subclade B3 by a Flag-2 locus insertion and par-C2 re-
combination, subclade B4 by Flag-2 locus and GI-PheV
insertions, and subclade B5 by Flag-2 locus and Phi3 in-
sertions. Other insertions, notably that of GI-PheV, re-
combination events, and mutations in gyrA and parC
occurred within strains of subclade B5, resulting in their
evolution to clade C and subclades C1 (H30-R) and C2
(H30-Rx). Epidemiologically, the 172 isolates consisted
of mostly those from North America obtained between
1948 and 2011, with most collected between 2000 and
2010, irrespective of the clade and subclade types. Since
the first description of the fimH lineage in 2013 [3], the
fimH type has been found in several epidemiological
studies published on ExPEC or fecal ST131 isolates [8–17].
However, these have mostly concerned fluoroquinolone-
resistant and /or ESBL-producing isolates. In 2006, we
retrieved non-ESBL-producing ST131 E. coli isolates,
susceptible or resistant to fluoroquinolones, from the intes-
tinal microbiota of 7% of healthy subjects living in the Paris
area [18]. The fluoroquinolone-resistant isolates accounted
for a subdominant E. coli population in four independent
healthy subjects, whereas those susceptible to fluoroquino-
lones accounted for the dominant E. coli population in
three other independent subjects. The latter finding
strongly suggests that ST131 E. coli is part of the normal
intestinal microbiota of humans. In the present study, we
aimed to determine whether these isolates belong to
different H subclones, based on their fluoroquinolone-
susceptibility pattern. The dominant fluoroquinolone-
susceptible ST131 E. coli populations belonged to subclone
H22. Assembled and annotated genomes of H22 strains
were not available when we performed the present study.
Thus, we first sequenced the whole genome of one of our
commensal H22 strains (S250) and compared it to the
genome of two reference ST131 strains: the ExPEC H30-Rx
strain JJ1886 and the commensal H41 strain SE15. This
genome comparison focused on virulence factor (VF)-en-
coding genes and those encoding processes or structures
(sugar metabolism, biofilm formation, and the FimH
mannose-binding site) known to be involved in the adapta-
tion of the bacteria to different environments including
human intestine. The four fluoroquinolone-resistant fecal
ST131 isolates were H30-R strains. Thus, we compared
them to the three fecal H22 strains considering the
genomic differences identified between H22 strain S250
and H30-Rx strain JJ1886, and analyzed the phenotypic
impact of some of these differences.
Methods
Bacterial strains
The seven fecal ST131 isolates (strains 02, 39, 183, 187,
196, 208, and S250) obtained from the intestinal micro-
biota of seven healthy subjects living in the Paris area in
2006 were included in the study. They display serotype
O25:H4, do not produce ESBL, and are either suscep-
tible (196, 208 and S250) or resistant (02, 39, 183 and
187) to fluoroquinolones [18]. The fluoroquinolone-
resistant strains were retrieved by plating the feces of
healthy subjects on nalidixic acid-containing plates. The
fluoroquinolone-susceptible strains accounted for the
dominant E. coli population of three subjects. We previ-
ously assessed the virulence potential of strain S250 in
the Caenorhabditis elegans and zebrafish models and
analyzed its genome by optical mapping. This strain had
a level of virulence similar to that of the multidrug
resistant ST131 isolates, with which it shared 86% gen-
ome similarity [19]. We also included the E. coli K-12
MG1655 reference strain in the study as a control in the
experiments assessing the use of gluconate as the sole
source of carbon.
fimH type
fimH typing was based on the internal 489-nucleotide
(nt) sequence of the fimH gene as previously
described [20].
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Antibiotic susceptibility
Antibiotic susceptibility was determined by the agar
diffusion method and interpreted following the 2015
EUCAST recommendations (www.eucast.org). The fol-
lowing antibiotics were tested: amoxicillin, amoxicillin +
clavulanic acid, ciprofloxacin, gentamicin, amikacin,
cotrimoxazole and fosfomycin.
Molecular analysis of resistance mechanisms
The genes encoding resistance to amoxicillin (TEM and
SHV enzymes) were identified by PCR and sequencing
methods as previously described [21]. The qnr genes en-
coding plasmid-mediated resistance to fluoroquinolones
were tested and the quinolone resistance determining
region (QRDR) of the genes gyrA, gyrB, parC and parE
amplified and sequenced using methods previously
described [21–23]. The QRDRs of our strains were
compared with those of the fluoroquinolone-susceptible
reference strain E. coli K-12 MG1655 [GenBank:
CP014225.1] and the allelic gyrA and parC profiles were
compared with those previously described for ST131
isolates [3].
Sequencing and analysis of the whole genome of H22
strain S250
The complete genomic sequence was determined for
H22 strain S250. Total DNA was extracted using the
Qiagen Blood & Cell Culture DNA Mini Kit (Qiagen,
Courtaboeuf, France). Libraries were constructed using
Nextera technology and sequenced on an Illumina
HiSeq-2000 using a 2 × 100 nucleotides (nt) paired-end
strategy. All reads were processed to remove low
quality or artefactual nucleotides, using sequentially
sickle (www.github.com/najoshi/sickle), AlienTrimmer
[24] and fqDuplicate (ftp.pasteur.fr/pub/gensoft/pro-
jects/fqtools). Read pairs were assembled using clc_as-
sembler from the CLC Genomics Workbench analysis
package (www.clcbio.com/products/clc-genomics-work-
bench). All contigs of ≥500 nt were reordered and reor-
iented, using the genomic sequence of strain E. coli K-12
MG1655 as a reference, with Mauve Contig Mover [25].
The reordered contigs were analyzed. The genome of
H22 strain S250 was compared to that of two reference
ST131 strains, JJ1886 (H30-Rx) [GenBank: CP006784.1]
and SE15 (H41) [GenBank: AP009378.1], focusing on
VF-encoding genes and genes involved in sugar metabol-
ism, biofilm formation, and methylation. We down-
loaded VFs (www.mgc.ac.cn/VFs/) available from the
Virulence Factor Database (VFDB) and searched the
three genomes for their presence using Prodigal v2.6.1
[26] and clustered them at 90% identity using CD-hit
v4.6 [27]. We extracted the sequences of the genes in-
volved in biofilm formation in strain E. coli K12
BW25113 [28] from its genome [GenBank: CP009273.1]
and clustered them at 90% identity with CD-hit. We
assessed the percentage identity between the genes from
E. coli K12 BW25113 and the three studied genomes.
Using the NBCI basic local alignment search tool
(BLAST), we blasted genes from E. coli K12 MG1655
against the S250, JJ1886, and SE15 genomes to verify the
possible absence of any genes involved in biofilm forma-
tion. We then searched the genomes of ST131 strains
S250, JJ1886, and SE15 for genes involved in sugar me-
tabolism as defined by Maltby et al. [29] in commensal
strains E. coli HS [GenBank: CP000802.1] and E. coli
Nissle 1917 [GenBank: CP007799.1] using BLAST.
Moreover, we also searched for all the genes involved in
gluconate metabolism (main pathway: gntR, gntT, gntU,
gntP, gntK; secondary pathway: idnT, idnDOTR; gene
idnK (gntV) which plays a role in the two pathways; the
Entner-Doudoroff pathway: edd and eda; additional
genes involved in other pathways: kdgT, kdgK, gnd, tkrA,
ghrB, kduD, dkgA and dkgB) [30], as well as the 100 base
pairs (bps) upstream of the start codon of each, in the
genome of strains S250 and JJ1886. The nucleotide se-
quence of the 100 bp-upstream regions and the se-
quences of the deduced proteins for each gene of the
strains S250 and JJ1886 were compared. We also
searched for genes encoding methyltransferases in
ST131 strain EC958 [GenBank: HG941718.1] [31] in the
genome of ST131 strains S250, JJ1886, and SE15 using
BLAST.
Subclade B and clade C typing
According to the work of Ben Zakour et al. [7], we de-
termined the subclade B type of H22 strain S250 and the
clade C type of strain JJ1886 by direct blasting of the
genes of the Flag-2 locus (Flag-2 locus from strain E. coli
042 [EMBL: CR 753847]), Phi3 (from strain EC958), and
GI-PheV (from strain JJ1886) against the genome of
strains S250 and JJI886. We then determined the type of
subclade B displayed by strain S250 and the two other
fecal H22 strains by PCR using primers specific for the
Flag-2 locus, Phi3, and GI-PheV (Additional file 1: Table
S1) and our H30-R fecal strains as a positive control.
Plasmid content
The plasmid content of H22 strain S250 was determined
using the PlasmidFinder system [32] and the FII, FIA,
and FIB formula of the detected IncF plasmid by PCR-
based replicon typing (http://pubmlst.org/plasmid/). The
latter method was also applied to the two remaining
fecal H22 strains and the four fecal H30-R strains.
ExPEC status and virotype
According to the study of Johnson and Adam, ExPEC
status is defined by the presence of ≥2 VF genes among
the following genes: pap, sfa/focDE, afa/draBC, iutA,
Nicolas-Chanoine et al. BMC Microbiology  (2017) 17:71 Page 3 of 12
and kpsMT II [33]. As the latter gene is not included in
the VFDB, we searched for it by blasting the kpsMT II
genes [GenBank: X53819] against the S250, JJ1886, and
SE15 genomes. Based on the study of Blanco et al., the
major virotypes of E.coli ST131 are defined using four
genes as follows: virotype A = afaFM955459+ iroN− ibeA
− sat +/−, virotype B = afaFM955459− iroN+ ibeA− sat+/−,
virotype C = afaFM955459− iroN− ibeA− sat+, and viro-
type D = afaFM955459+/− iroN+/− ibeA+ sat+/− [34]. As
afaFM955459 is not included in the VFDB, we searched
for it by blasting the afaFM955459 operon [EMBL:
FM955459] against the S250, JJ1886, and SE15 genomes
[35]. Then, classic multiplex PCR was used to search for
genes encoding ExPEC-associated VFs (Additional file 2:
Table S2) [34] in the seven fecal strains to confirm the
results provided by the direct genome analysis of strain
S250 and to determine the VF profile, virotype, and
ExPEC status of the six remaining fecal strains.
FimH structure
According to the study of Sokurenko et al., the amino
acid variations observed within the sequence of the
adhesin, FimH, of type 1 fimbriae, result in different
levels of binding to mono-mannose (M1) structures,
whereas they have no impact on the normal high level of
binding to tri-mannose (M3) structures [36]. By measur-
ing the ratio of M1/M3 binding in different experimental
models, they defined low M1-binding (M1/M3 < 0.1) and
high M1-binding (M1/M3 > 0.90) FimH phenotypes and
showed that they are related to specific FimH sequences
[37]. Therefore, the deduced protein sequence of FimH
of H22 strain S250 was compared with that of H30-Rx
ST131 strain JJ1886 [GenBank: AGY86963.1], H41
ST131 strain SE15 [GenBank: BAI57801.1], phylogroup
A E. coli strain MG1655 [GenBank: AMC97175.1], and
two other phylogroup B2 strains: ST73 strain CFT073
[GenBank: AAN83822.1] and ST131 uk_P46212 [Gen-
Bank: ALT52319.1]. The deduced protein sequence of
FimH was then characterized for the six remaining fecal
strains by using primers for which the sequences have
been previously published [20].
Amplification and sequencing of the idnK (gntV) and ghrB
genes of the seven fecal strains and growth with
gluconate as the sole carbon source
The idnk (gntV) gene, encoding a thermosensitive D-
gluconate kinase, and the ghrB gene, encoding a gluco-
nate reductase, were amplified with primers indicated in
Additional file 1: Table S1. Additional primers were used
to sequence the ghrB gene (Additional file 1: Table S1).
We evaluated the ability of the seven strains to grow in
the presence of gluconate as the sole carbon source, as
previously described [38]. Experiments were conducted
three times independently and all incubations were
performed overnight at 37 °C with shaking (150 rpm).
Briefly, bacteria were first cultured in Mueller Hinton
broth before washing twice in minimal media M63
[15 mM (NH4)2SO4; 100 mM KH2PO4; 0.002 mM
FeSO4 (7H2O)]. We inoculated 5 ml of M63 supple-
mented with 0.2% glucose (Sigma-Aldrich, France) with
10 μl of the washed bacteria. One ml of this culture was
washed twice in M63. We transferred 10 μl of this
washed culture into 5 ml of M63 with 0.2% gluconate
(Sigma-Aldrich, Saint-Quentin Fallavier, France). The
cultures were then adjusted to 0.002 at OD600 in 30 ml
fresh M63 with 0.2% gluconate and incubated at 37 °C
with shaking (150 rpm). We estimated the bacterial
growth after 48 h by measuring the OD600 [39]. Tukey’s
test was used for intergroup comparisons and R software
for statistical analyses. P values <0.01 were considered to
be statistically significant.
Amplification and sequencing of the fimB gene and
kinetics of biofilm formation in the seven fecal strains
The fimB gene was amplified and sequenced with the
primers indicated in Additional file 1: Table S1. The kin-
etics of early biofilm formation was assessed using the
BioFilm Ring Test® (BioFilm Control, Saint Beauzire,
France), as described [40]. Briefly, standardized bacterial
cultures were incubated at 37 °C in a 96-well microtiter
plate in the presence of magnetic beads. At various time
points, the plates were placed onto a magnetic test block
and put in the reader. The images of each well before
and after magnetic attraction were analyzed using
BioFilm Control software that gives a BioFilm Index
(BFI). The BFI was converted into the proportion of
immobilized beads relative to a reference condition (%
RBI) using the formula: % RBI = √[(1-(BFIassay-BFImin)/
(BFIcontrol-BFImin)] ×100, where BFIassay is the BFI of the
tested strain, BFIcontrol is the BFI of the control, corre-
sponding to the maximum BFI, and BFImin is the
minimal observed BFI when all the beads are blocked.
The more RBI approaches a value of 1, the more the bio-
film is fully formed (beads are immobilized). Three
experiments were performed in duplicated per strain
and per incubation time. The kinetics of biofilm forma-
tion were compared using a two-way ANOVA followed
by Dunnett’s multiple comparisons test.
Results
fimH type, antibiotic susceptibility, molecular analysis of
resistance mechanisms, and allelic profiles of the gyrA
and parC genes
The three fluoroquinolone-susceptible strains (S250, 208
and 196) were of the fimH22 type. All but one were
susceptible to all of the antibiotics tested (Table 1). H22
strain 196 was resistant to both amoxicillin and cotri-
moxazole. The four fluoroquinolone-resistant strains
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(187, 183, 39 and 02), which were all resistant to amoxi-
cillin but susceptible to the other antibiotics tested, were
of the fimH30 type (H30-R) (Table 1). QRDR nucleotide
sequence analysis showed that the three H22 strains dis-
played gyrA1a and parC1 alleles, whereas the four H30-
R strains displayed the gyrA1AB allele, encoding amino
acid substitutions S83 L and D87N, and the parC1aAB
allele, encoding amino acid substitutions S80I and E84V
(Table 1). We found the substitution I529L in ParE in
the seven fecal strains (Table 1). None of these strains
harbored plasmid-mediated qnr genes. H22 196 and the
four H30-R strains that were resistant to amoxicillin har-
bored a TEM-1-encoding gene (Table 1).
Genomic and phenotypic characterization
We assembled the whole genome sequence of the fecal
H22 strain S250 into 50 contigs and analyzed and com-
pared it with those of the ExPEC H30-Rx strain JJ1886
and the commensal H41 strain SE15.
Subclade B and C type
We were unable to find the genes composing the Flag-2
locus in the genome of H22 strain S250 using BLAST.
We only found a fragment of approximately 1700 bp
which was very similar to the end of the first gene, IfhA,
and another of 769 bp similar to the end to the last gene,
lafU, of the Flag-2 locus (data not shown). We found
neither Phi3 nor GI-PheV in the genome of H22strain
S250, whereas we found them, as well as the Flag-2
locus, in the genome of JJ11886. The use of specific
primers allowed us to confirm the absence of these gen-
etic elements in H22 strain 250 and to detect the Flag-2
locus in H22 strains 196 and 208, as well as GI-PheV in
H22 strain 196. These three genetic elements were amp-
lified from our four H-30R strains (Table 1).
VF-encoding genes
Using a gene identity level of ≥90%, a total of 173 genes
among the 2520 Escherichia sp. VF-encoding genes of
the VFDB was identified in the genomes of the three
ST131 strains studied. H22 strain S250, H30-Rx strain
JJ1886, and H41 strain SE15 had 160, 159, and 152 VF-
encoding genes, respectively. The three ST131 genomes
shared 148 virulence genes (Fig. 1). Nine genes were
found specifically in H22 strain S250: the five iroBCDEN
genes that encode proteins related to a catecholate sid-
erophore, the three pixCDH genes encoding Pix pilus
adhesion, and the ibeA gene involved in invasion of
brain endothelium (Fig. 1). Ten genes were specifically
found in H30-RX strain JJ1886: the four iucABCD and
iutA genes encoding proteins involved in the binding
and transport of iron, the pap1 and papX genes
encoding pap operon regulatory proteins, the sat gene
encoding a toxin, the flu gene encoding autotransporter
protein Ag43a, and the iha gene encoding the adhesion-
siderophore receptor. Three genes, including the fimB
gene, were present in strains H22 S250 and H41 SE15,
but not H30-RX strain JJ1886 (Fig. 1). The ECP_2810
gene, encoding a Val-Gly Repeats-related protein, was
present in H41 strain SE15 and H30-RX strain JJ1886.
Virotype and ExPEC status
The VF genes identified in the VFDB would suggest
virotype D (ibeA+, iroN+, and sat−) for strain S250 and
virotype C (sat+, ibeA−, and iroN−) for strain JJ1886.
These virotypes were confirmed by the absence of the
Table 1 Characterization of the seven fecal strains of E. coli ST131
Strain/ FimH
type
Susceptibility β-lactamase Allele typea
(amino acid substitution)
Flag-2 Phi3 GI-PheV Subclade IncF
plasmid
replicon
AMX AMC CIP GEN AMK SXT FOS gyrA parC parE
S250/H22 S S S S S S S − 1a 1 NA
(I529L)
− − − B1 F89:A-:B62
208/H22 S S S S S S S − 1a 1 NA
(I529L)
+ − − B2 −
196/H22 R S S S S R S TEM-1 1a 1 NA
(I529L)
+ − + B4 F24:A-:B6






+ + + C1 F1:A2:B20






+ + + C1 F1:A2:B20






+ + + C1 F1:A2:B20






+ + + C1 F1:A2:B20
aaccording to reference [3], AMX amoxicillin, AMC amoxicillin + clavulanic acid, CIP ciprofloxacin, GEN gentamicin, AMK amikacin, SXT cotrimoxazole, FOS
fosfomycin, R resistant, S susceptible, −: absence, +: presence, NA not available
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afaFM955459 operon in the genome of strains S250 and
JJ1886, shown using BLAST. We were unable to deter-
mine a virotype for strain SE15, as none of the four
genes were detected in the genome of this strain. Com-
bining VFDB-based and BLAST analysis of the kpsMT II
gene, we found that strains S250 and SE15 did not dis-
play an ExPEC status, as they harbored only one (kpsMT
II) of the genes used to define this status. Multiplex PCR
classically used to search for genes encoding ExPEC-
associated VF (Additional file 2: Table S2) to the seven
fecal strains showed that the two remaining fecal H22
strains displayed virotype D, as strain S250, and the four
fecal H30-R strains virotype C, as strain JJ1186 (Table 2).
It also showed that only virotype C H30-R strain 39 dis-
played an ExPEC status related to the presence of the
iutA and kpsMT II genes. We found 11 of the amplified
VF genes (fimH, matB, pet, chuA, fyuA, irp2, sitA, traT,
malX, usp and ompT) in all but one (strain H22 208)
strain, five (F10 papA, iha, sat, iucD and iutA) in only
H30-R strains, and four (cdt, iroN, iss and ibeA) in only
H22 strains. The number of amplified VF-encoding
genes varied from 15 to 17 in H30-R strains and 13 to
16 in H22 strains.
Deduced protein FimH
As indicated in Fig. 2, the deduced protein sequence of
adhesin FimH of representatives of H30-Rx ST131 E. coli
(strains JJ1886 and uk_P46212), H41 ST131 E. coli
(strain SE15), H22 ST131 E. coli (strain S250), UPEC
(ST73 strain CFT073), and E. coli K12 (strain MG1655)
displayed amino acid differences at the positions previ-
ously shown to characterize different M1/M3 ratio phe-
notypes, contributing to different levels of colonization
of different niches [37]. Thus, we identified the sequence
-A27, N70 and S78 or N78 and S70, V163, and R166-
corresponding to the lower M1/M3 ratio (0.08-0.09) in
Table 2 Virulence factor-encoding genes, virotype, and ExPEC status of human fecal ST131 Escherichia coli H22 and H30 subclones
Strain fimH Virulence factor-encoding gene Virotype ExPEC status
S250 H22 fimH, matB, pet, iroN, chuA, fyuA, irp2, sitA, kpsMII-K5, iss, traT, ibeA, malX, usp, ompT D -
208 H22 fimH, matB, cdtB, pet, chuA, fyuA, irp2, sitA, kpsMII-K5, ibeA, malX, usp, ompT D -
196 H22 fimH, matB, cdtB, pet, iroN, chuA, fyuA, irp2, sitA, kpsMII-K5, iss, traT, ibeA, malX, usp, ompT D -
187 H30 fimH, F10 papA, iha, matB, sat, pet, iucD, iutA, chuA, fyuA, irp2, sitA, traT, malX, usp, ompT C -
183 H30 fimH, F10 papA, iha, matB, sat, pet, iucD, iutA, chuA, fyuA, irp2, sitA, traT, malX, usp, ompT C -
39 H30 fimH, F10 papA, iha, matB, sat, pet, iucD, iutA, chuA, fyuA, irp2, sitA, kpsMII-K5, traT, malX, usp, ompT C +
02 H30 fimH, F10 papA, matB, sat, pet, iucD, iutA, chuA, fyuA, irp2, sitA, traT, malX, usp, ompT C -
Fig. 1 List of genes found in the genomes of H22 strain S250, H30-Rx strain JJ1186 and, H41 strain SE15. Each strain is represented by a circle and
each gene commonly found in the genome of two strains or in the genome of the three strains is indicated in the corresponding intersecting
regions, whereas genes specific for each strain are indicated in the section of the circle not shared with another circle. The 148 genes present in
the three strains are listed at the bottom of the figure
Nicolas-Chanoine et al. BMC Microbiology  (2017) 17:71 Page 6 of 12
the study of Sokurenko et al. in strain SE15. We found
the substitutions A27V and V163A, that are each related
to a ten-fold increase in the M1/M3 ratio in the Sokur-
enko et al., study in strain MG1655 and strain CFT073,
respectively. We also found the substitution R166H
related to a M1/M3 ratio of 0.33 in the same study in
H30-Rx strains JJ1886 and uk_P46212. H22 strain S250
displayed a sequence not published in the Sokurenko et
al. study as residue N was present at both positions 70
and 78. However, we found none of the substitutions
known to induce an increase in the M1/M3 ratio in the
FimH sequence of strain S250. We found the same fea-
ture in the two other fecal H22 strains, whereas the
FimH sequence of our four H30-R strains was identi-
cal to that of H30-Rx strains JJ1886 and uk_ P46212
(data not shown).
Genes involved in sugar metabolism and growth with
gluconate as the sole carbon source
All genes involved in sugar metabolism in commensal E.
coli strains HS and Nissle were detected in the genome
of H41 strain SE15, whereas one, the D-gluconate
kinase-encoding idnK (gntV) gene, was not detected in
either strain H30-Rx JJ1886 or H22 S250 (Table 3). Its
absence in our six remaining strains was revealed by the
PCR-sequencing assay. Therefore, we assessed the ability
of our strains to grow with gluconate as the sole carbon
source in the absence of the idnK (gntV) gene and the
presence of the gntK gene, which both transform D-glu-
conate to 6P-gluconate. After 48 h of growth, the bio-
mass of our H30-R strains was significantly lower than
that for our H22 strains (Tukey’s test p < 0.01) (Fig. 3). This
unexpected difference led us to compare the genomes of
strains H22 S250 and H30-Rx JJ1886 focusing on all the
genes, other than the idnk (gtnV) gene, involved in gluco-
nate metabolism, as well as the 100 bp upstream of the start
codon of the operons or genes. All were present in the gen-
ome of strains S250 and JJ1886. The 100 bp upstream of
the start codon and the sequence of the deduced proteins
showed 100% identity (data not shown) between these two
strains, except for the coding region of the ghrB gene,
which showed a T968C substitution, resulting in amino
acid substitution V323A in strain JJ1886. This substitution
was confirmed in our four fecal H30-R strains, whereas
V323 was identified in the two remaining H22 fecal strains.
Biofilm genotype and phenotype
The expression of a wide panel of genes can influence
biofilm formation [28]. We specifically searched for
these genes in the genome of strains JJ1886, S250, and
SE15 (Additional file 3: Table S3). Two genes of the bio-
film gene panel, fliC and fliD, were missing from the
three tested genomes. We aligned the fliC and fliD genes
from E. coli strain MG1655 onto the three genomes
(JJ1886, S250 and SE15) to verify their absence and
found deletions within fliC and the absence of fliD in
the three strains. An intact version of the fimB gene was
present in strains H22 S250 and H41 SE15, but it was
disrupted in H30-Rx JJ1886 due to the insertion of IS3-
like, as previously described in various H30 strains [34,
41]. The difference in the structure of the fimB gene in
strains H30-Rx JJ1886 and H22 250 led us to sequence
the fimB gene of the remaining fecal strains. We found
that the fimB nucleotide sequence in the four H30-R
strains was identical to that of H30-Rx strain JJ1886,
Fig. 2 Alignment of FimH sequence from various Escherichia coli
strains. Phylogroup B2 E. coli: ST73 strain CFT073, H30 ST131 JJ1886,
H30 ST131 uk_P46212, H22 ST131 S250 and H41 ST131 SE15;
phylogroup A: MG1655. “1” indicates the start of the FimH protein.
Amino acid positions involved in binding to mono-mannose and
tri-mannose structures are indicated in grey
Table 3 Distribution of the genes involved in sugar metabolism
in commensal Escherichia coli strains HS and Nissle [29] in the













araA Arabinose + + +
araB Arabinose + + +
araD Arabinose + + +
fucK Fucose + + +
galK Galactose + + +
gntK Gluconate + + +
idnK Gluconate − − +
lacZ Lactose + + +
manA Mannose + + +
nagE N-acetylglucosamine + + +
nanA N-acetylneuraminate + + +
nanT1 N-acetylneuraminate + + +
rbsK Ribose + + +
uxaC Glucuronate + + +
E. coli Nissle 1917
agaA N-acetylgalactosamine + + +
agaE N-acetylgalactosamine + + +
agaF N-acetylgalactosamine + + +
agaW N-acetylgalactosamine + + +
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whereas that of the two remaining H22 strains was iden-
tical to that of strain S250. Niba et al. previously
reported that the deletion of fliC and/or fliD induces a
substantial decrease in biofilm formation, whereas dele-
tion of fimB results in in its near complete absence
(Additional file 3: Table S3). We thus tested whether this
fimB polymorphism affects biofilm formation. Kinetic
measurements of early biofilm formation showed that
the three H22 strains formed biofilms significantly earl-
ier (p < 0.0001) than the four H30-R strains (Fig. 4). Of
note, H30-R strain 39, which was the single fecal strain
with an ExPEC status, showed significantly (p< 0.0001)
slower biofilm production (incomplete biofilm formation
after 24 h) than the other H30-R strains.
Genes encoding methyltransferases
We found all but one of the ten methyltransferases, previ-
ously identified in the genome of H30 ST131strain EC958
[31], in the genome of H30-Rx strain JJ1886 (Table 4). We
found six in the genome of H41 strain SE15 and only
three in the genome of H22 strain S250 (Table 4).
Plasmid content
We detected an IncFII plasmid in contig 4 and an
IncFIB element in contig 41 of the S250 genome using
PlasmidFinder. Using NCBI BLAST and the plasmid
MSLT typing system, we identified the replicon alleles
Fig. 3 Growth of human fecal subclone H30 and subclone H22 strains of ST131 Escherichia coli in minimal medium plus 0.2% gluconate. Strain
growth was assessed by measuring the OD at 600 nm after 48 h of incubation. Bars represent the standard deviation obtained from three
independent experiments
Fig. 4 Early biofilm formation by human fecal subclone H30 and
subclone H22 strains of ST131 Escherichia coli. BioFilm Control®
image analysis software was used and results are expressed as the
proportion of immobilized beads relative to reference conditions
(% RBI) according to incubation time. Bars represent the standard
deviation obtained from three independent experiments performed
in duplicate. The biofilm is more fully formed (beads are
immobilized) as RBI approaches a value of 1. Significant differences
between H22 and H30 using Dunnett’s test are indicated by *
(p < 0.05), ** (p < 0.01) and *** (p < 0.001)
Table 4 Distribution of the 10 methyltransferases previously
described in H30 strain EC958, [31] in the genomes of
representative H30, H22, and H41 subclones of Escherichia coli ST131
Methyltransferase (H30 EC958) H30 JJ1886 H22 S250 H41 SE15
M.EcoMIV + − −
M.EcoMV + − −
M.EcoMDcm + + +
EcoMIII + − +
M.EcoMVI + + +
M.EcoMDam + + +
M.EcoMVII − − −
M1.EcoMI + − +
M2.EcoMI + − +
M.EcoMII + − −
Total number 9 3 6
+: presence,-: absence
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F89 and B62 in the whole genome of strain S250. We
confirmed this result for strain S250 by PCR-sequencing,
and also obtained the following results for the six
remaining fecal strains: F1:A2:B20 for the four H30-R
strains, no IncF plasmid for H22 strain 208, and F24:B6
for H22 strain 196 (Table 1).
Discussion
CTX-M-15 producing, fluoroquinolone-resistant ST131
E. coli, which has been shown to be a worldwide human
ExPEC since the beginning of the 2000s, has also been
shown to colonize the human digestive tract [1]. In
2006, we found healthy subjects with a subdominant in-
testinal population of fluoroquinolone-resistant ST131 E.
coli, as well as those with a dominant intestinal popula-
tion of ST131 E. coli susceptible to fluoroquinolones
[18]. The latter finding suggests that ST131 E. coli may
be a human intestinal commensal. Here, we first showed
that our three antibiotic-susceptible fecal ST131 E. coli
strains displayed fimH22, whereas the four resistant to
fluoroquinolones displayed fimH30 (H30-R). We thus
centered our study on the comparison between these
two groups of strains focusing on processes and struc-
tures involved in environmental adaptation, considering
that subclone H22 is the precursor of subclone H30,
which emerged at the end of 1990s [3, 7]. We first se-
quenced the whole genome of one of our fecal H22
strains, strain S250, as there were no assembled and an-
notated genomes of H22 strains when we started our
work. In contrast, there were sequenced whole genomes
of representative multidrug resistant H30 ExPECs, such
as H30-RX strain JJ1886 and a commensal ST131 E. coli,
strain SE15, belonging to another ST131 subclone, char-
acterized by the allele fimH41. Comparison of the ge-
nomes of H22 strain S250, H30-Rx strain JJ1886, and
H41 strain SE15 showed high similarity in terms of the
number and types of VF genes from the VFDB. This
may explain the similar level of virulence that we found
previously between H22 strain S250 and an H30-Rx
strain in the C. elegans model [19, 42]. Nevertheless,
strains S250 and JJ1886 displayed two different virotypes:
D for strain S250 and C for strain JJ1886. Moreover,
strain S250 did not display the VF genes required for
ExPEC status, whereas strain JJ1886 did [43]. There was
also high similarity between the genes involved in bio-
film formation in the three genomes [28], except for the
fimB gene, which was disrupted in the H30-Rx strain
JJ1886 and intact in both H22 strain S250 and H41
strain SE15. As the intact fimB gene was also absent
from our fecal H30-R strains and present in our
remaining fecal H22 strains, we analyzed the kinetics of
early biofilm formation in our seven fecal strains. Biofilm
formation was significantly delayed in the H30-R strains.
This is the first study to compare the formation of
biofilms by H22 and non-ESBL-producing H30-R strains
[4, 42, 44–46]. Further studies are required to verify the
involvement of the fimB gene in the two different bio-
film phenotypes. Comparison of the genes of the three
genomes involved in the metabolism of various sugars
showed the absence of one of the two genes encoding
gluconate kinases in strains S250 and JJ1886. Although
this gene was absent in both our fecal H22 and H30-R
strains, we found that H22 strains had a higher capacity
to grow in medium with gluconate as the sole carbon
source. Thus, gluconate consumption may confer an
advantage to H22 strains for residing in the human in-
testine, as gluconate is a component of intestinal mucus
[47]. Indeed, it has been shown that E. coli laboratory
mutants with impaired growth on gluconate are less able
to colonize the large intestine of mice [38]. Comparison
of all genes, and their promoter regions, involved in the
different pathways of gluconate metabolism showed one
difference between strains S250 and JJ1886, namely a
mutation leading to an amino acid substitution in the
2-keto-D-gluconate reductase GhrB in strain JJ1886. Al-
though this genetic difference was found between the
fecal H22 and H30-R strains, further studies are required
to clarify the role of this mutation for the difference in
the growth of the two strains when gluconate is the sole
carbon source. Another difference we identified between
strain S250 and strain JJ1886 concerned the sequence of
the type 1 fimbriae FimH adhesin, shown by Sokurenko
et al. to be involved in variations of the M1/M3 ratio
associated with tissue tropism and the shift of bacterial
adaptation from a commensal to pathological habitat
[36, 37]. The FimH sequence of strain JJ1886, which was
also present in our H30-R fecal strains, corresponded to
that identified by Sokurenko et al. in strains with a M1/
M3 ratio = 0.33. This sequence and M1/M3 ratio are
commonly observed in uropathogenic strains [36, 37].
The FimH sequence identified in strain S250 and the
other fecal H22 strains was not found in the strains
studied by Sokurenko et al. and was only found at a low
frequency in those studied by Chen et al. [48]. This se-
quence showed none of the amino acid substitutions in-
volved in the increase of the M1/M3 ratio. Thus it is
likely to be associated with the lowest M1/M3 ratio
shown by Sokurenko et al., which was associated with
strong adhesion to intestinal cells [36, 37]. Altogether,
although the H22 and H30-R strains investigated in this
work were all isolated from the digestive tract of healthy
subjects, only H22 strains displayed properties previ-
ously shown to be associated with human intestinal
commensalism, including competition for nutrients in
the intestine (gluconate use) and a high intestinal adhe-
siveness [49].
We sought to confirm the genetic differences identi-
fied here between the lineages H22 and H30 with the
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whole genome sequences of ST131 isolates recently de-
posited on NCBI databases (i.e. 28 H22 strains, 9 H30
strains, see Additional file 4: Table S4). As expected, we
retrieved all but one of these genetic differences in this
wider H22 and H30 strain collection. Indeed, the gluco-
nate reductase-encoding ghrB gene in two H22 clinical
isolates (strain JJ1897 and strain GN02448 from the bio-
project PRJNA290784: Additional file 4: Table S4)
displayed the same sequence as in all H30 strains and
not that found in the other H22 strains. Of note, these
two strains possessed Phi3 and the par-C1a variant, the
two evolutionary markers present in the H22 “intermedi-
ate” strain group B0/C0 described by Ben Zakour et al.
[7]. The intermediate status was based on the SNP
pattern of H22 strains which progressively acquired
clade C-defining point mutations.
The last comparison made between the S250, JJ1886
and SE15 genomes concerned the genes encoding the 10
methyltransferases previously identified in the genome of
H30-Rx ST131strain EC958 [31]. We found nine of these
genes in strain JJ1886, six in strain SE15, and only three in
strain S250. Forde et al. showed that six of the 10 genes
detected in strain EC958 are components of defined mo-
bile genetic elements (MGE) that we showed to be absent
from the genome of H22 strain S250. Indeed, we showed
that this strain belongs to subclade B1, meaning tothe an-
cestor of subclone H22 from which evolved the four other
B subclades and subclone H30 with its subclades C1 and
C2. Subclone H30 arose by acquiring, among others,
MGEs near which the methyltransferase-encoding genes
are located in H30-Rx strain EC958. The three genes iden-
tified in strain S250 encode orphan methyltransferases
known to be involved in regulation and not methyltrans-
ferases involved in restriction modification systems known
to inhibit the uptake of non-self DNA and restrict
horizontal gene transfer.
We also showed that strain S250 had a gyrA1 allele. This
allele was not found in the subclade B1 strains studied by
Ben Zakour et al., whereas it was found in some of their
strains belonging to subclades B4 and B5 [7]. Concerning
our two other fecal H22 strains that harbored the gyrA1a
allele, we showed that one belonged to subclade B2 and
the other to subclade B4. Plasmid content also varied
within our H22 strains: no IncF plasmid in one strain and
IncF plasmids with different replicons, F24:B6 and
F89:B62, in the two remaining H22 strains, with allele B62
identified here (strain S250) for the first time. Johnson et
al. also found plasmids with FII and FIB replicons in most
of their H22 strains. However, the two FII and FIB allelic
patterns identified by Johnson et al. were different from
ours [6]. In contrast, our H30-R strains were all of the
same subclade with the same plasmid content: subclade
C1 and the IncF plasmid with the replicon F1:A2:B20-.
This replicon was previously identified in France in CTX-
M-27-producing, fluoroquinolone-resistant H30 strains iso-
lated from stool of children attending different day-care
centers in 2012 [14]. It was also very recently shown by
Johnson et al. to be the dominant IncF plasmid replicon
type among the fluoroquinolone-resistant H30 strains
(called H30R1) from different sources whereas replicon
F2:A1 was shown to be dominant in those H30 strains pro-
ducing CTX-M-15 (H30-Rx) [6].
Conclusions
This study shows, for the first time, that the O25b:H4
ST131 E. coli isolates that were carried in the intestinal
microbiota of healthy subjects living in the Paris area in
2006 consisted of strains belonging to both the ancient
dominant subclone H22 and the current dominant sub-
clone H30. The genotypic and phenotypic differences
identified in this study between these two subclones
affect their ability to adapt to the environment. The fecal
H22 strains displayed traits increasing their ability to
colonize human gut, whereas the fecal H30-R strains
displayed traits allowing extra-intestinal adaptation.
Thus, resistance to antibiotics may not be the sole
advantage of subclone H30-R over its precursor sub-
clone H22 in causing worldwide infections.
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